Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

C Coe

Showing results (111-120 of 113) with videos related to

Pageof 12
Sort By:
You have reached the last page of results.This site can display upto 113 results.
The Journal of Pathology|February 14, 2018
The diabetes drug liraglutide reverses cognitive impairment in mice and attenuates insulin receptor and synaptic pathology in a non-human primate model of Alzheimer's diseaseAndre F Batista, Leticia Forny-Germano, Julia R Clarke, et al.
Brain Communications|March 27, 2023
Cognitive correlates of antisaccade behaviour across multiple neurodegenerative diseasesHeidi C Riek, Donald C Brien, Brian C Coe, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|November 1, 2022
Characteristics of the Ontario Neurodegenerative Disease Research Initiative cohortKelly M Sunderland, Derek Beaton, Stephen R Arnott, et al.
Pageof 12

Showing results (111-120 of 113) with videos related to

Sort By:
Pageof 12
You have reached the last page of results.This site can display upto 113 results.
The Journal of Pathology|February 14, 2018
The diabetes drug liraglutide reverses cognitive impairment in mice and attenuates insulin receptor and synaptic pathology in a non-human primate model of Alzheimer's diseaseAndre F Batista, Leticia Forny-Germano, Julia R Clarke, et al.
Brain Communications|March 27, 2023
Cognitive correlates of antisaccade behaviour across multiple neurodegenerative diseasesHeidi C Riek, Donald C Brien, Brian C Coe, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|November 1, 2022
Characteristics of the Ontario Neurodegenerative Disease Research Initiative cohortKelly M Sunderland, Derek Beaton, Stephen R Arnott, et al.
Pageof 12